Listen to the original episode
About this episode
Dr. Masud Husain is a Professor of Neurology & Cognitive Neuroscience at the University of Oxford and a leading expert on the science of motivation, apathy, and neurological diseases. We discuss how dopamine and specific brain circuits shape motivation, including how the brain weighs the trade-off between effort vs reward when deciding what goals to pursue. Dr. Husain also explains practical tools to increase motivation, reduce distractions, and make it easier to start and maintain goal pursuit. We also discuss dementia, Parkinson’s and Alzheimer’s disease, including new insights into cognitive resilience and factors that help protect against age-related cognitive decline.
Show notes: https://go.hubermanlab.com/masud-husain-295
Thank you to our sponsors
AG1: https://drinkag1.com/huberman
David: https://davidprotein.com/huberman
BetterHelp: https://betterhelp.com/huberman
Eight Sleep: https://eightsleep.com/huberman
Function: https://functionhealth.com/huberman
Timestamps
(00:00:00) Masud Husain
(00:02:24) Apathy, Motivation
(00:08:07) Rewards, Apathy & Motivation; Dopamine
(00:13:20) Sponsors: David & BetterHelp
(00:15:44) Types of Apathy; Goal Prioritization: Effort vs Rewards
(00:23:26) Motivation, Apathy, Tool: Activation Energy & Overthinking
(00:29:24) Tools to Increase Motivation: Incentives, Subdivide Tasks, Planning
(00:35:13) Subjective Effort, Mental Framing; Learning & Motivation
(00:42:24) Sponsors: AG1 & Eight Sleep
(00:44:54) Perseverance, Failure; Finding Your Passion, Depression vs Apathy
(00:50:58) Self-Concept, Ambition; Life Satisfaction
(00:58:25) Psychedelics, Anhedonia & Changing Self
(01:03:09) Personal & Social Identity, Tools: Curiosity, Purpose & Dementia Risk
(01:11:58) Addiction, Dopamine; Social Media & Dopamine "Hits"?
(01:18:36) Sponsor: Function
(01:20:13) Dopamine, Parkinson's Disease; Other Roles of Dopamine
(01:26:59) Life Purpose, Culture; Reflection, Weighing Decisions
(01:34:21) Internal & External Attention
(01:39:59) Internal Chatter, Distraction; Working Memory, Stimulants, Nicotine
(01:48:54) ADHD, Diagnosis; Attention & Motivation
(01:54:34) Goal Planning & Perseverance
(01:59:44) Alzheimer's Disease, Dementia, Apathy, Tools: Dementia Risk Factors
(02:06:55) Neurodegenerative Disease & Emerging Treatments
(02:10:59) Can You Train Attention?, Tool: Reduce Distraction
(02:15:14) Enrichment, Art
(02:17:45) Zero-Cost Support, YouTube, Spotify & Apple Follow, Reviews & Feedback, Sponsors, Protocols Book, Social Media, Neural Network Newsletter
Disclaimer & Disclosures
Learn more about your ad choices. Visit megaphone.fm/adchoices
Episode summary
This AI-generated Shortcast summary may omit nuance. Use the original episode when context or exact wording matters.
Almost every addictive drug, from nicotine and alcohol through heroin, cocaine, and amphetamine, commandeers dopamine circuitry. When that system is impaired, people can become profoundly apathetic; when driven too hard, hypermotivated. Dopamine is not the whole story, but it matters enormously for how strongly we pursue an outcome.
Welcome to the Huberman Lab Podcast. I’m Andrew Huberman, and my guest is Oxford neurologist and neuroscientist Dr. Masud Husain. I wanted to start with apathy. Is it simply a lack of motivation, or something more specific in the brain?
About fifteen years ago, we saw David, a man in his thirties who had gone from successful, sociable, and productive to, frankly, “I can’t be bothered.” He lost his job and home, barely cared for himself, yet was not sad or hopeless. He was quite happy. He wanted to listen to music, but setting up speakers and cables felt like too much for the pleasure expected. Tiny strokes on both sides of his ventral striatum had disrupted circuits that translate desire into action.
So he still had wanting, but the small amount of work between wanting music and hearing it felt enormous. That sounds less like depression than a break between desire and engagement.
Exactly. People with apathy will work for a large reward, but modest rewards seem not worth the exertion. We tried L-dopa without much effect, then ropinirole, which stimulates dopamine D2 and D3 receptors. Three months later, I scarcely recognized David: showered, haircut, suit, new job, and a new girlfriend. Those very small lesions had nearly extinguished motivation.
People can be driven at work but not socially, emotionally, or intellectually engaged. Is there one general motivation system or separate systems for different goals?
The mesolimbic pathway, linking basal ganglia and frontal cortex, is rather like a final common route into action, but the signals feeding it differ. There can be behavioral, social, emotional, and cognitive apathy. At any moment, the brain weighs anticipated reward against physical, cognitive, emotional, or social effort. One option wins, much of that calculation outside awareness.
I love “activation energy.” Some people see an experiment and simply go, “Let’s do it.” Others lose enormous energy deciding whether to start. Low activation energy seems like a spectacular advantage in life.
In Oxford students choosing whether reward justified physical effort, more apathetic students still chose high rewards but passed on lower ones. Their ventral striatum and medial frontal regions were more active while deciding: they seemed to burn more brain fuel for the same choice. You can lower the barrier by breaking a task into smaller parts or altering its incentive. Often the hardest part is initiating; planning ahead also avoids paying every little decision cost.
Make the reward meaningful, make effort seem smaller, and do not confront a three-month project as one mountain. Finish one part, get acknowledgement, then move on. You are not receiving energy from the sky; you may be reducing the burden created by how a task is framed. Dopamine matters both for effortful choice and learning from outcomes, but completion is another essential component of motivation.
It is important to separate apathy from depression. David had little action but no sadness. Others can be deeply depressed yet retain drive, and some have both. Ambition itself is not well understood mechanistically, and it does not guarantee happiness. Still, I would be wary of imposing artificial limits. There is a difference between realism and unnecessarily confining yourself.
The self is not fixed in stone. Hormones, brain injury, Parkinson’s, Alzheimer’s, memory, attention, language, and impulse control can alter how we experience and present ourselves. We have personal identity—this body, memories, and choices over time—and social identity: family, work, faith, community, and the stories we tell. New actions and relationships can change us without erasing continuity.
That matters for aging. Social relationships, curiosity, new interests, and purpose are associated with lower cognitive-decline risk. Twenty to thirty percent of people without dementia have Alzheimer-type changes at post-mortem, so resilience matters. Apathy may precede obvious symptoms; in otherwise healthy older people, high self-reported apathy is associated with roughly twice the later risk of Alzheimer’s disease.
There’s so much loose talk about scrolling for dopamine. People can pursue something they do not even like, which sounds very much like doomscrolling.
Evidence for neat “dopamine hits” from scrolling is not strong. But wanting differs from liking. Dopamine strongly modulates pursuit and incentive; hedonic pleasure seems more related to opioid systems. You can keep seeking something while no longer enjoying it. Dopamine also affects movement, working memory, planning, inhibition, and executive control. In Parkinson’s, a person may struggle to move normally but run from a burning house: urgent motivation can engage the action system.
Attention seems bound up with this. We have limited processing capacity, and most people feel they have too much inner chatter.
External events and internal thoughts compete for limited resources. A falling object captures attention bottom-up; searching for someone in red is top-down. Working memory is limited too: the more items you hold, the poorer each representation becomes. Training often improves the exact task practiced without broad transfer, but removing distractions—notifications, email, noise—changes what can capture attention.
I use a deathbed decision: looking back at the end, would I think this was valuable, useful, or worthy of pride for me, my family, or somebody else? If not, and I have the option, I say no. Sometimes you must chop wood and carry water, but I try to devote myself to what will still seem valuable later. That is where the juice is for me.
And for enrichment, you draw and paint—not because it must become a career or impress anybody, but because it gives you intrinsic pleasure.
Exactly. Even half an hour drawing something with no value to anybody else can be deeply satisfying. It is simply for you, perhaps improving a skill, and that is a very good definition of enrichment.
Dr. Masud Husain, thank you. Your work makes pathology understandable, but also gives us a better way to think about effort, attention, purpose, pleasure, and changing how we move through life.
Thanks for a really stimulating conversation.